PapersFlow Research Brief
Ginkgo biloba and Cashew Applications
Research Guide
What is Ginkgo biloba and Cashew Applications?
Ginkgo biloba and Cashew Applications refers to the cluster of research examining therapeutic effects of Ginkgo biloba extracts for neuroprotection, dementia prevention, cognitive enhancement, and antioxidant properties, with no direct studies on cashew applications within the provided data.
This field encompasses 23,352 papers on Ginkgo biloba's pharmacokinetics, terpene trilactones, flavonoids, and roles in mitigating cognitive impairment and Alzheimer's disease. Research highlights its neuroprotective and antioxidant effects linked to dementia and memory enhancement. Growth rate over the past 5 years is not available in the data.
Topic Hierarchy
Research Sub-Topics
Ginkgo biloba Neuroprotective Mechanisms
This sub-topic investigates cellular and molecular pathways by which Ginkgo extracts protect neurons from oxidative stress and apoptosis. Researchers study flavonoid and terpenoid effects on mitochondrial function and inflammation.
Ginkgo biloba in Dementia Clinical Trials
This sub-topic evaluates randomized controlled trials of standardized Ginkgo extracts for Alzheimer's disease and vascular dementia symptom management. Researchers assess cognitive outcomes, safety profiles, and dose-response relationships.
Pharmacokinetics of Ginkgo biloba Constituents
This sub-topic examines absorption, distribution, metabolism, and excretion of ginkgolides, bilobalide, and flavonoids in humans. Researchers use LC-MS methods to study bioavailability enhancements and drug interactions.
Antioxidant Properties of Ginkgo biloba
This sub-topic analyzes free radical scavenging, metal chelation, and enzyme modulation by Ginkgo polyphenolics in vitro and in vivo. Researchers correlate antioxidant capacity with neuroprotective outcomes.
Ginkgo biloba for Cognitive Enhancement
This sub-topic explores Ginkgo's effects on memory, attention, and executive function in healthy adults and mild cognitive impairment patients. Researchers conduct neuroimaging and neuropsychological assessments.
Why It Matters
Studies in this field address neuroprotection against cognitive decline, with applications in dementia associated with Parkinson's disease and mild cognitive impairment. For instance, Emre et al. (2007) established clinical diagnostic criteria for dementia in Parkinson's patients, where Ginkgo biloba's antioxidant properties may offer supportive roles given the field's focus. Zheng and Wang (2001) measured antioxidant capacities in herbs, reporting ORAC values from 1.88 to 22.30 micromol of Trolox equivalents, underscoring potential benefits for chronic conditions like neurodegeneration. Hertog et al. (1993) linked dietary flavonoids to reduced coronary heart disease risk in the Zutphen Elderly Study, paralleling Ginkgo biloba's flavonoid components for cardiovascular and cognitive health.
Reading Guide
Where to Start
"Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study" by Hertog et al. (1993), as it provides foundational evidence on flavonoid benefits with 4342 citations, introducing antioxidant concepts relevant to Ginkgo biloba.
Key Papers Explained
Hertog et al. (1993) establish dietary flavonoids' role in reducing heart disease risk, connecting to Zheng and Wang (2001), which quantifies antioxidant activity in herbs at 1.88-22.30 micromol TE. Emre et al. (2007) builds diagnostic frameworks for PD dementia, while Litvan et al. (2012) extends to mild cognitive impairment criteria, and Lyketsos et al. (2002) quantifies neuropsychiatric prevalence, all aligning with Ginkgo biloba's neuroprotective applications.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Field centers on Ginkgo biloba's role in dementia and cognitive impairment, with no recent preprints or news available. Emphasis remains on established papers like those on Parkinson's burden by Dorsey et al. (2018) and projections by Dorsey et al. (2006).
Papers at a Glance
Frequently Asked Questions
What are the main therapeutic focuses of Ginkgo biloba research?
Ginkgo biloba extracts are studied for neuroprotection, dementia prevention, cognitive enhancement, and antioxidant properties. Key compounds include terpene trilactones and flavonoids. Applications target cognitive impairment and Alzheimer's disease.
How do antioxidants from herbs like those in Ginkgo biloba perform?
Zheng and Wang (2001) found antioxidant capacities in medicinal herbs ranging from 1.88 to 22.30 micromol of Trolox equivalents. Total phenolic contents vary accordingly. These metrics indicate strong free radical scavenging potential.
What diagnostic criteria exist for dementia in Parkinson's disease?
Emre et al. (2007) defined clinical criteria for dementia associated with Parkinson's disease, recognizing it as common in older patients. The Task Force outlined specific diagnostic features. These aid in distinguishing PD-D from other dementias.
What is the prevalence of neuropsychiatric symptoms in dementia?
Lyketsos et al. (2002) reported neuropsychiatric symptoms in the majority of dementia cases and high prevalence in mild cognitive impairment. Population-based estimates show serious consequences. Ginkgo biloba research contexts address these via neuroprotection.
What evidence exists for dietary flavonoids in health?
Hertog et al. (1993) demonstrated dietary antioxidant flavonoids reduce coronary heart disease risk in the Zutphen Elderly Study. This links to Ginkgo biloba's flavonoids. Protective effects extend to chronic diseases.
What is mild cognitive impairment in Parkinson's disease?
Litvan et al. (2012) provided Movement Disorder Society Task Force guidelines for diagnosing mild cognitive impairment in PD patients. It serves as a harbinger of dementia. Criteria focus on nondemented individuals.
Open Research Questions
- ? How do Ginkgo biloba's terpene trilactones and flavonoids specifically interact with Parkinson's disease pathology to prevent dementia?
- ? What are the precise pharmacokinetic profiles of Ginkgo biloba compounds in patients with cognitive impairment?
- ? Can Ginkgo biloba antioxidants mitigate neuropsychiatric symptoms in mild cognitive impairment as observed in population studies?
- ? Which mechanisms link Ginkgo biloba's neuroprotective effects to Alzheimer's disease progression?
- ? How do bioavailability factors of Ginkgo biloba phenolics influence outcomes in dementia prevention?
Recent Trends
No recent preprints or news coverage available in the last 12 months.
The field maintains focus on 23,352 works without specified 5-year growth data.
Citation leaders include Hertog et al. at 4342 citations on flavonoids.
1993Research Ginkgo biloba and Cashew Applications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ginkgo biloba and Cashew Applications with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers